Government news, all in one place
Government news, all in one place
The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.
Based on publicly published press releases (last 12 months)
878 articles
Showing 1-30
Tuesday, 21 July 2026
The new inhalers use a next-generation propellant designed to reduce environmental impact while maintaining the same established treatment....
Friday, 17 July 2026
As part of the ‘Summer-proof your health’ campaign, the MHRA is reminding people that heat and poor storage, at home or while travelling, can affect h...
Thursday, 16 July 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025–26 Annual Report and Accounts highlighting a year of strong and ...
Wednesday, 15 July 2026
The MHRA is strengthening safety warnings for all botulinum toxin type A products, following reports of rare cases of botulism linked to their use....
Wednesday, 15 July 2026
Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK?donor plasma for five high?priority plasma-derived medicinal pro...
Friday, 10 July 2026
As football fans across the country get behind England, the MHRA wants to keep any Yellow Cards off the pitch – and instead let people know that Yello...
Thursday, 09 July 2026
The MHRA is urging people to “summer-proof your health” as warmer weather, travel, and changing routines can affect how medicines and medical devices ...
Wednesday, 08 July 2026
The MHRA’s Criminal Enforcement Unit dismantled a multimillion-pound criminal network responsible for illegally supplying medicines. ...
Wednesday, 08 July 2026
As with any medicinal product, the MHRA will keep the safety and effectiveness of nerandomilast under close review.??...
Monday, 06 July 2026
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in th...
Friday, 03 July 2026
The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis....
Thursday, 02 July 2026
MHRA CEO argues that for the UK’s long-term health and prosperity, regulation should help lead, rather than follow, innovation...
Wednesday, 01 July 2026
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close ...
Wednesday, 01 July 2026
MHRA investigation secures fraud convictions linked to the supply of non-compliant medical devices....
Friday, 19 June 2026
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants....
Thursday, 18 June 2026
The MHRA, Advertising Standards Authority, and the General Pharmaceutical Council have issued a warning to businesses seeking to promote newly authori...
Monday, 15 June 2026
MHRA and FDA liaison programme announced to improve regulatory collaboration and support long-standing international partnership....
Friday, 12 June 2026
Dr Nicola Rose, Executive Director of Science and Research at the Medicines and Healthcare products Regulatory Agency (MHRA), has been appointed an OB...
Friday, 12 June 2026
As with any medicine, the MHRA will keep the safety and effectiveness of the adrenaline nasal spray under close review.??...
Thursday, 11 June 2026
Having met the MHRA’s rigorous standards of safety, quality and effectiveness, the semaglutide tablet has been approved in the UK for weight loss and ...
Thursday, 11 June 2026
The MHRA is publishing the results of an extensive public consultation which will inform the recommendations of the AI Commission and future regulatio...
Wednesday, 10 June 2026
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly...
Tuesday, 09 June 2026
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing....
Tuesday, 09 June 2026
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review....
Friday, 05 June 2026
Avacopan is used in the treatment of some rare autoimmune diseases affecting small blood vessels. ...
Thursday, 04 June 2026
The adjuvanted trivalent influenza vaccine works by stimulating the immune system to produce its own protection against flu....
Wednesday, 03 June 2026
Resmetirom is used in?adults who have experienced inflammation and cell damage, resulting in scarring....
Friday, 29 May 2026
The raid on a Northamptonshire estate dismantled what is believed to be a major illicit manufacturing and distribution operation...
Friday, 29 May 2026
As with any medicine, the MHRA will keep the safety and effectiveness of rilzabrutinib under close review. ...
Thursday, 28 May 2026
Patients taking Crescent Pharma Limited Ramipril 2.5mg capsules are advised to check their packaging for batch number GR155023 and contact their pharm...